Subramanian Kannan, Murali M B Venkataraman, Salila S Chandorkar
{"title":"QRISK 3<sup>®</sup> and ASCVD Risk Calculator in Patients with Diabetes and Their Correlation with Coronary Artery Calcium Scores.","authors":"Subramanian Kannan, Murali M B Venkataraman, Salila S Chandorkar","doi":"10.4103/ijem.ijem_27_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Diabetes mellitus is an independent risk factor for asymptomatic cardiovascular disease (CVD). The QRISK 3<sup>®</sup> score and atherosclerotic cardiovascular disease (ASCVD) risk scores determine the risk of developing CVD over 10 years. The CT coronary artery calcium score (CACS) is a non-invasive imaging modality that identifies sub-clinical atherosclerosis. We studied the correlation between the QRISK 3<sup>®</sup> and ASCVD scores and the CACS and determined the cut-off for QRISK 3<sup>®</sup> and ASCVD scores that corresponded to a moderate or accentuated CACS (≥100).</p><p><strong>Methods: </strong>In this prospective study, outpatients with diabetes and no prior coronary artery disease (CAD) or their equivalents, or having symptoms suggestive of angina or heart failure, had their QRISK 3<sup>®</sup> and ASCVD scores calculated. They subsequently underwent 256 slice cardiac CT, and CACS was calculated by the Agatston method.</p><p><strong>Results: </strong>A statistically significant correlation (r = 0.28) was found between QRISK 3<sup>®</sup> and ASCVD with CACS (<i>P</i> = 0.004 and <i>P</i> = 0.007, respectively). A QRISK<sup>®</sup> score >23 and ASCVD score >10 predicted a CACS score >100 with sensitivities of 85% and 90%, respectively.</p><p><strong>Conclusion: </strong>The QRISK 3<sup>®</sup> and ASCVD scores can be used to triage patients who require further evaluation with CACS to determine the risk of future CVD.</p>","PeriodicalId":13353,"journal":{"name":"Indian Journal of Endocrinology and Metabolism","volume":"28 6","pages":"639-644"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11774411/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Endocrinology and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijem.ijem_27_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Diabetes mellitus is an independent risk factor for asymptomatic cardiovascular disease (CVD). The QRISK 3® score and atherosclerotic cardiovascular disease (ASCVD) risk scores determine the risk of developing CVD over 10 years. The CT coronary artery calcium score (CACS) is a non-invasive imaging modality that identifies sub-clinical atherosclerosis. We studied the correlation between the QRISK 3® and ASCVD scores and the CACS and determined the cut-off for QRISK 3® and ASCVD scores that corresponded to a moderate or accentuated CACS (≥100).
Methods: In this prospective study, outpatients with diabetes and no prior coronary artery disease (CAD) or their equivalents, or having symptoms suggestive of angina or heart failure, had their QRISK 3® and ASCVD scores calculated. They subsequently underwent 256 slice cardiac CT, and CACS was calculated by the Agatston method.
Results: A statistically significant correlation (r = 0.28) was found between QRISK 3® and ASCVD with CACS (P = 0.004 and P = 0.007, respectively). A QRISK® score >23 and ASCVD score >10 predicted a CACS score >100 with sensitivities of 85% and 90%, respectively.
Conclusion: The QRISK 3® and ASCVD scores can be used to triage patients who require further evaluation with CACS to determine the risk of future CVD.
期刊介绍:
The Indian Journal of Endocrinology and Metabolism (IJEM) aims to function as the global face of Indian endocrinology research. It aims to act as a bridge between global and national advances in this field. The journal publishes thought-provoking editorials, comprehensive reviews, cutting-edge original research, focused brief communications and insightful letters to editor. The journal encourages authors to submit articles addressing aspects of science related to Endocrinology and Metabolism in particular Diabetology. Articles related to Clinical and Tropical endocrinology are especially encouraged. Sub-topic based Supplements are published regularly. This allows the journal to highlight issues relevant to Endocrine practitioners working in India as well as other countries. IJEM is free access in the true sense of the word, (it charges neither authors nor readers) and this enhances its global appeal.